PitchBook clients can access the complete Excel data pack via the Research Center on the PitchBook Platform.
Healthcare services dealmaking slows in Q4—but 2026 should bring a rebound
Healthcare services deal activity rose 9.6% YoY in 2025 to an estimated 747 transactions, even as total deal value fell 1.6% amid fewer closings and a meaningful pause in dealmaking in Q4. Regulatory friction, particularly for physician practice management (PPM) assets in states such as California, and uncertainty around 2026 premium subsidies slowed momentum late in the year. Still, 2025 delivered several headline transactions, including Cencora’s $7.4 billion acquisition of OneOncology for a majority of the remaining equity it did not already own, Ascension’s $3.9 billion purchase of AMSURG, and multibillion-dollar LBOs of Dentalcorp Holdings and home infusion provider KabaFusion.
Beneath the surface, deal activity diverged sharply by subsector. Skilled nursing facilities, specialty pharmacy, hospitals & health systems, and intellectual & developmental disability practices led growth, while PPM deal count declined 18%, driven by steep pullbacks in gastroenterology, fertility, ENT, and dental. Notably, PPM exits jumped 57.1% in 2025, an early signal that transaction volume could recover in 2026, especially in oncology and musculoskeletal. With public valuation multiples near long-term averages and hospital systems signaling renewed interest in ambulatory surgical centers and PPMs, the adoption of AI (particularly in revenue cycle and practice efficiency) will be the key catalyst shaping healthcare services valuations and M&A in the year ahead.
Table of contents
| PE activity | 3 |
| Healthcare services PE ecosystem market map | 8 |
| Healthcare services PE investor map | 9 |
| Segment data | 10 |
| Generalist & multispecialty providers | 11 |
| Ancillary & outsourced services | 12 |
| Physician practice management companies | 14 |
| Skilled care & behavioral health | 17 |
| Healthcare services PE league tables | 19 |
The fourth quarter slowing on near-term policy uncertainty creates pent-up demand in 2026. 2025 represents a 9.6% increase from a 2024 bottom in healthcare services dealmaking.